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A novel regulatory mechanism for control of the ubiquitous
2-oxoglutarate dehydrogenase complex (ODH), a key enzyme of the
tricarboxylic acid cycle, was discovered in the actinomyceteCoryne-
bacterium glutamicum, a close relative of important human patho-
gens like Corynebacterium diphtheriae and Mycobacterium tuber-
culosis. Based on the finding that a C. glutamicum mutant lacking
serine/threonine protein kinase G (PknG) was impaired in gluta-
mine utilization, proteome comparisons led to the identification of
OdhI as a putative substrate of PknG.OdhI is a 15-kDa protein with
a forkhead-associated domain and a homolog of mycobacterial
GarA.Byusingpurifiedproteins, PknGwas shown tophosphorylate
OdhI at threonine 14. The glutamine utilization defect of the
pknG mutant could be abolished by the additional deletion of
odhI, whereas transformation of a odhI mutant with a plasmid
encoding OdhI-T14A caused a defect in glutamine utilization.
Affinity purificationofOdhI-T14A led to the specific copurification
of OdhA, the E1 subunit of ODH. Because ODH is essential for
glutamine utilization, we assumed that unphosphorylated OdhI
inhibits ODH activity. In fact, OdhI was shown to strongly inhibit
ODH activity with a Ki value of 2.4 nM. The regulatory mechanism
described offers a molecular clue for the reduced ODH activity that
is essential for the industrial production of 1.5 million tons/year of
glutamate with C. glutamicum. Moreover, because this signaling
cascade is likely to operate also inmycobacteria, our results suggest
that the attenuated pathogenicity of mycobacteria lacking PknG
might be caused by a disturbed tricarboxylic acid cycle.
Increasing numbers of eukaryotic-like serine/threonine protein
kinases found in bacteria implicate that they play important roles in cell
signaling, but their targets and specific functions are largely unknown
(1). The genome of the important human pathogen Mycobacterium
tuberculosis encodes 11 members of this protein family (2). Among
these, protein kinaseG (PknG)2 gained particular interest because it was
reported to inhibit phagosome-lysosome fusion, thus allowing for intra-
cellular survival of mycobacteria. Deletion of the pknG gene in Myco-
bacterium bovis BCG resulted in lysosomal localization and mycobac-
terial cell death in infected macrophages. PknG was detected in the
cytosol of infected macrophages and was therefore suggested to inter-
fere with host cell signaling pathways (3). A pknG deletionmutant ofM.
tuberculosis displayed decreased viability upon infection of immuno-
competent mice but also reduced growth in vitro (4), implying that
PknG function is not restricted to the pathogenic life style. This is sup-
ported by the fact that genes encoding PknG homologs are not only
present in pathogenicmycobacteria but also in all othermembers of the
suborder Corynebacterineae with known genome sequence, i.e. species
of the genera Corynebacterium,Mycobacterium, Nocardia, and Rhodo-
coccus, as well as in Streptomyces species. To determine the function of
PknG, we chose Corynebacterium glutamicum, a nonpathogenic spe-
cies used for biotechnological amino acid production (5), which already
proved useful for understanding the function of homologous genes in
M. tuberculosis (6).
EXPERIMENTAL PROCEDURES
Bacterial Strains and Culture Conditions—The strains and plasmids
used in this study are listed in Table 1. C. glutamicum strains were
cultivated aerobically in shake flasks at 150 rpm and 30 °C in brain heart
infusion medium (Difco) or CGXII minimal medium (7) with 200 mM
glucose. For growth experiments on glutamine as carbon and nitrogen
source, C. glutamicum was precultured overnight in brain heart infu-
sion medium with 100 mM glucose. Cells were harvested, washed with
0.9% NaCl, and used to inoculate the main cultures in glutamine
medium (modifiedCGXII lacking ammonium sulfate and urea and con-
taining 100 mM glutamine) supplemented with 5 mM glucose. Samples
for determination of intracellularmetabolites and for proteome analysis
were taken after 12 h of cultivation when the pknG strain just became
stationary after glucose depletion. For the determination of growth
rates, cells grown in brain heart infusion medium with glucose were
cultivated in glutaminemediumwith 20mMglucose. The cells from this
second preculture were used to inoculate glutamine medium without
glucose. For all cloning purposes, Escherichia coli DH5 was used and
routinely grown in Luria-Bertani medium at 37 °C. When appropriate,
kanamycin was added at concentrations of 25 mg/liter (C. glutamicum)
or 50 mg/liter (E. coli).
Construction of Plasmids and Mutants—The oligonucleotides used
as PCR primer in this study are listed in Table S1. Plasmids were con-
structed by standard molecular genetic methods and confirmed by
DNA sequence analysis. Defined C. glutamicum deletion mutants were
constructed by crossover PCR and double homologous recombination
using the suicide vector pK19mobsacB (8). All deletionswere verified by
Southern blot analysis. Site-directed mutagenesis of odhI was carried
out by PCR using themutagenic primer pairs T14A-for/-rev and T15A-
for/-rev. For construction of C. glutamicum strains synthesizing Strep-
tagged OdhA or Strep-tagged AceE, 3-terminal fragments of the
respective genes were amplified with the primer pairs odhA-for/odhA-
rev and aceE-for/aceE-rev. The reverse primers introduced a Strep-
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tag-II coding sequence before the stop codon. After cloning the PCR
products into the suicide vector pK18mob, the resulting plasmids were
integrated into theC. glutamicum chromosome by a single homologous
recombination event. Recombinant strains were selected on agar plates
containing kanamycin.
Determination of InternalGlutamine/GlutamateConcentrations—Cul-
ture samples containing 0.5–1 mg of biomass (dry weight) were rapidly
filtered through glass fiber disks (Millipore), and the filter-bound cells
were washed with 0.9% NaCl at room temperature (9). Internal metab-
olites were extracted by incubating harvested cells in 1.3 ml of 50 M
ornithine for 15 min at 95 °C. Amino acids in the extracts were quanti-
fied by high pressure liquid chromatography after precolumn deriva-
tization with o-phthaldialdehyde. Internal concentrations were calcu-
lated using a correlation of dry weight (mg/ml)  0.25  A600 and a
cytoplasmic volume of 1.5 l/mg dry weight (10). The correlation
between dry weight and OD600 was determined for three independent
cultures of wild type and pknGmutant and was found to be identical.
Two-dimensional Gel Electrophoresis and Protein Identification—Cyto-
solic proteins were isolated and separated by two-dimensional gel electro-
phoresis as described (11). Protein identification from Coomassie-stained
one- or two-dimensional gels and analysis of theOdhI phosphorylation site
was performedbypeptidemass fingerprinting of tryptic digests and post-
source decay analysis of the phosphorylated peptide using a Voyager
DE-STR mass spectrometer (Applied Biosystems, Weiterstadt, Ger-
many) as described (11).
Preparation of Cell-free Extracts and Protein Purification by Affinity
Chromatography—All steps were performed at 4 °C. Generally, cells
were resuspended in buffer A (100mMTris/HCl, pH 8.0, 150mMNaCl)
containing Complete EDTA-free protease inhibitor (Roche Diagnos-
tics) and disrupted by sonication or French press treatment. Cell debris
was removed by low speed centrifugation (18,000 g for 10 min). Prior
to purification, cell extracts from C. glutamicum were incubated with
avidin (50 g/mg protein) for 30 min to reduce copurification of the
biotinylated proteins pyruvate carboxylase and acyl-CoA carboxylase.
Strep-tagged PknG, OdhI, and mutated derivatives were purified from
C. glutamicum pknG/pEKEx2-pknGSt and E. coli DH5 containing
pAN3K-odhI, pAN3K-odhI-T14A, or pAN3K-odhI-T15A, respectively,
by affinity chromatography on Strep-Tactin-Sepharose columns (1-ml
bed volume, IBA, Go¨ttingen, Germany). Cell extracts (5 mg of pro-
tein/ml) were applied to the column and washed with 6 ml of buffer A,
and bound proteins were eluted in 3 ml of buffer A with 2.5 mM des-
thiobiotin. Fractions containing the purified proteins were concen-
trated by ultrafiltration and stored frozen at 20 °C in elution buffer
containing 20% (v/v) glycerol. For copurification attempts of OdhI and
OdhA on analytical scale, Strep-Tactin-coated magnetic beads (IBA,
Go¨ttingen) were used. 10 mg of beads were activated according to the
supplier’s instructions, equilibrated in buffer A, and mixed with 2 ml of
cell extract. After 1 h of incubation with occasional shaking, the beads
were separated andwashed five timeswith 200l of bufferA, and bound
proteins were eluted in 100 l of buffer A with 2.5 mM desthiobiotin.
TABLE 1
Plasmids and C. glutamicum strains used in this study
Description Ref.
Strains
ATCC13032 Biotin-auxotrophic wild-type strain 39
pknG Wild type derivative with in-frame deletion of pknG (cg3046) This work
glnH Wild type derivative with in-frame deletion of glnH (cg3045) This work
glnX Wild type derivative with in-frame deletion of glnX (cg3044) This work
odhI Wild type derivative with in-frame deletion of odhI (cg1630) This work
pknGodhI pknG derivative with additional in-frame deletion of odhI This work
WT-odhASt Wild type derivative with plasmid pK18mob-odhASt integrated into the chromosomal odhA
gene (cg1280) adding a Strep-tag-II coding sequence before the odhA stop codon
This work
pknG-odhASt As above but pknG derivative This work
WT-aceESt Wild type derivative with plasmid pK18mob-aceESt integrated into the chromosomal aceE
gene (cg2466) adding a Strep-tag-II coding sequence before the aceE stop codon
This work
pknG-aceESt As above but pknG derivative This work
Plasmids
pEKEx2 KanR, C. glutamicum expression vector for IPTG-inducible gene expression 40
pEKEx2-pknGSt pEKEx2 derivative containing the C. glutamicum pknG gene with the native
ribosome-binding site and a Strep-tag-II coding sequence before the pknG stop codon
This work
pAN3K KanR, derivative of the E. coli expression vector pASK-IBA3C (IBA, Göttingen, Germany)
for anhydrotetracycline-inducible production of C-terminally Strep-tagged proteins,
contains the KanR gene and the C. glutamicum replicon from pJC1 allowing plasmid
replication and gene expression in C. glutamicum
This work
pAN3K-odhI and derivatives pAN3K derivative containing the C. glutamicum wild-type odhI gene (obtained by PCR
with primers OdhI-for-1/rev-1) or mutated odhI genes with Thr-14 or -15 codons
exchanged to alanine codons
This work
pJC1 KanR, E. coli-C. glutamicum shuttle vector 41
pJC1-odhI and derivatives (T14A, T15A) pJC1 derivatives containing the C. glutamicum wild-type odhI gene (obtained by PCR with
primers OdhI-for-2/-rev-2) with its native promoter or mutated odhI genes with Thr-14
or -15 codons exchanged to alanine codons; a Strep-tag-II coding sequence before the
odhI stop codon was introduced by the reverse primer
This work
pK18mob KanR, E. coli vector unable to replicate in C. glutamicum 42
pK18m-odhASt pK18mob derivative containing a 625-bp PCR product covering the 3-terminal end of the
odhA gene elongated with a Strep-tag-II coding sequence before the stop codon
This work
pK18m-aceESt pK18mob derivative containing a 578-bp PCR product covering the 3-terminal end of the
aceE gene elongated with a Strep-tag-II coding sequence before the stop codon
This work
pK19mobsacB KanR, E. coli vector for generating C. glutamicum deletion mutants 42
pK19ms-pknG pK19mobsacB derivative containing a crossover PCR product (primer pknG-1–4) that
covers the flanking regions of the pknG gene
This work
pK19ms-glnH pK19mobsacB derivative containing a crossover PCR product (primer glnH-1–4) that
covers the flanking regions of the glnH gene
This work
pK19ms-glnX pK19mobsacB derivative containing a crossover PCR product (primer glnX-1–4) that
covers the flanking regions of the glnX gene
This work
pK19ms-odhI pK19mobsacB derivative containing a crossover PCR product (primer odhI-1–4) that
covers the flanking regions of the odhI gene
This work
Control of 2-Oxoglutarate Dehydrogenase by Protein Kinase G
MAY 5, 2006•VOLUME 281•NUMBER 18 JOURNAL OF BIOLOGICAL CHEMISTRY 12301
 at R
sch Cntr Julich Res library on August 6, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
For 2-oxoglutarate dehydrogenase (ODH) and pyruvate dehydrogen-
ase (PDH) activity assays and for purification of active ODHPDH com-
plexes, cells were disrupted in buffer B (50 mM TES/NaOH, pH 7.7, 10
mMMgCl2)with 30% (v/v) glycerol. Cell extracts for enzyme assayswere
gel-filtrated in the same buffer on PD10 columns (Amersham Bio-
sciences) to remove interfering intracellular metabolites. ODHPDH
complexes were purified on Strep-Tactin-coated magnetic beads or
Strep-Tactin-Sepharose (for subsequent enzyme assays) essentially as
described above, but cell extracts were dilutedwith buffer B to 15% (v/v)
glycerol, and buffer A was replaced by buffer B containing 10% (v/v)
glycerol.
Enzyme Assays—Autokinase activity of PknG and PknG-dependent
phosphorylation of OdhI was assayed in kinase buffer (25mMTris/HCl,
pH 7.5, 5 mM MgCl2, 2 mM MnCl2, 1 mM dithiothreitol) as described
(12). Oxoglutarate dehydrogenase and pyruvate dehydrogenase activity
were measured at 30 °C in a photometric assay by following the initial
increase in absorbance of NADH at 340 nm (13). Assays containing
buffer B with 3 mM L-cysteine, 0.9 mM thiamine diphosphate, 2 mM
NAD, 50 M chlorpromazine (to prevent reoxidation of NADH (14)),
25–100 l of cell extract, or purified ODHPDH complexes and up to
30.4 nMOdhI were preincubated for 10min at 30 °C before the reaction
was started by addition of 1.5 mM 2-oxoglutarate or pyruvate and 0.2
mM coenzymeA.An activity of 1 unit refers to 1mol ofNADH formed
per min.
Miscellaneous—Protein concentrations were determined with the
Bradford protein assay using bovine serum albumin as standard. Glu-
tamine uptake rates of cells grown in CGXII/glucose to the mid-log
phase were determined using 1-[14C]glutamine and a filtration assay
as described (15).
RESULTS
PknG Is Required for Glutamine Utilization in C. glutamicum—The
C. glutamicum pknG gene (cg3046) is located in a putative operon (Fig.
1A) with two genes, cg3044 (glnX) and cg3045 (glnH), that encode a
hypothetical membrane protein with four potential transmembrane
helices and a putative “periplasmic” glutamine-binding lipoprotein,
respectively (16). This gene arrangement is conserved in bacteria con-
taining pknG homologs except for Streptomyces coelicolor and Strepto-
myces avermitilis where an additional open reading frame is present
between glnH and pknG. Because GlnH homologs of other bacteria, e.g.
E. coli or Bacillus subtilis, are part of ABC transporters for high affinity
glutamine uptake, we tested the effect of an in-frame pknG deletion inC.
glutamicum on glutamine utilization. As shown in Fig. 1B, C. glutami-
cum wild type grew on minimal medium agar plates with glutamine as
sole carbon and nitrogen source, whereas growth of the pknGmutant
was severely inhibited. This phenotype could be complemented by plas-
mid-borne pknG (data not shown). In liquid glutamine medium, C.
glutamicum wild type showed a growth rate of 0.17–0.20 h1 and
formed 5 g of cell dry weight liter1 within 20 h. The pknG strain
showed no growth within this period. The mutant started to grow only
after a prolonged incubation. This growth was probably because of sup-
pressor mutations, because the lag phase of different cultures varied
considerably, and cells from these cultures could subsequently grow
immediately on glutamine agar plates. No significant growth differences
were observed on rich medium or glucose minimal medium (data not
shown). To study the role of GlnX and GlnH for glutamine utilization,
in-frame deletionmutants ofC. glutamicum lacking either glnX or glnH
were constructed (Fig. 1A). On glutamine agar plates, both mutants
showed a growth defect (Fig. 1B). In liquid glutamine medium, the
glnXmutant showed a similar phenotype as thepknGmutant. There
was no growth within 50 h, but upon prolonged incubation suppressor
mutants started to grow. By contrast, the glnH mutant was able to
grow in liquid glutamine medium, with growth rates varying from 0.14
to 0.16 h1. From these results, a function of PknG, GlnX, and GlnH in
glutamine uptake or metabolism could be inferred.
C. glutamicum possesses a secondary Na-dependent glutamine
uptake system that has not yet been genetically identified (15). Trans-
port assays were performed to studywhetherGlnH andGlnX are part of
a glutamine transporter that is regulated by PknG. However, the C.
glutamicummutant strains lacking pknG, glnX, or glnH showed at least
80% of the glutamine transport activity of the wild type (data not
shown), indicating that the defect of the mutants in glutamine utiliza-
tion is not because of an impaired glutamine uptake. A similar result was
reported for a M. bovis BCG pknG mutant (17). Measurement of the
internal amino acid concentrations revealed that the glutamate level
was 2-fold higher in the pknG mutant compared with the wild type
and the complemented mutant, whereas the glutamine level was only
slightly increased (Fig. 1C). Therefore, a defect in glutamate catabolism
was likely to be responsible for the defect of the pknGmutant in glu-
tamine utilization.
Identification of an in Vivo Substrate of PknG—To find themolecular
basis for inhibition of glutamate catabolism by PknG, we searched for
in vivo phosphorylation substrates of PknG by proteome analysis of C.
glutamicum wild type, pknG mutant, and complemented mutant
grown on 100 mM glutamine and 5 mM glucose as carbon sources.
Comparison of Coomassie-stained two-dimensional gels revealed a
series of three spots in the acidic, low molecular mass range that clearly
differed between the wild type and complemented pknG strain on the
one hand and the pknGmutant on the other hand (Fig. 1D). All three
spots were identified by mass spectrometry as the protein encoded by
gene cg1630, which was designated OdhI. OdhI (143 amino acid resi-
FIGURE 1.Genomic organizationof thepknGgeneand consequences of its deletion
in C. glutamicum. A, the pknG gene for protein kinase G is clustered with glnX and glnH
encoding an integralmembraneprotein of unknown function andaputativeglutamine-
binding lipoprotein, respectively. The chromosomal deletions present in strains pknG,
glnX, and glnH are indicated. B, growth of C. glutamicum wild type (Wt) and strains
lacking pknG, glnH, or glnX on minimal medium agar with 100 mM glutamine as sole
carbon source after 3 days at 30 °C. C and D, phenotypic characterization of C. glutami-
cum wild type, pknG mutant, and complemented pknG mutant during growth in
minimalmediumwith 100mMglutamine and5mMglucose.C, internal concentrations of
glutamate and glutamine. The data represent mean values  S.D. of three separate
cultures.D, sections of representative two-dimensional gels showing threeprotein spots
(indicated with arrows) with altered abundance in the pknG mutant compared with
wild type and complemented pknGmutant. The spots correspond to the unphospho-
rylated (spot 0),monophosphorylated (spot 1) andputativedoubly phosphorylated (spot
2) form of OdhI (encoded by cg1630).
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dues, 15,402 Da) is a homolog (69% sequence identity) of Mycobacte-
rium smegmatis GarA (18) and contains a forkhead-associated (FHA)
domain, which binds phosphothreonine epitopes on proteins andmedi-
ates phosphorylation-dependent protein-protein interactions (19). The
pI values of 4.64, 4.56, and 4.47 observed for the three OdhI spots were
close to the theoretical values calculated for unphosphorylated, mono-
phosphorylated, and doubly phosphorylatedOdhI protein, respectively.
The amount of the different OdhI isoforms was relatively quantified by
densitometric analysis of the two-dimensional gels. In the wild type
61.5 6.4% of total OdhI was present in the monophosphorylated and
5.5  3.9% in the doubly phosphorylated form (all data are mean val-
ues S.D. of three gels from independent cultures). The complemented
pknG mutant showed no significant differences with corresponding
values of 53.1  14.3 and 2.0  1.8%, respectively. In contrast, the
pknGmutant contained only 5.9 0.1% monophosphorylated OdhI,
and the doubly phosphorylated formwas undetectable. These data sug-
gest that OdhI is phosphorylated by PknG but also by at least one addi-
tional protein kinase. Besides PknG,C. glutamicum possesses homologs
of theM. tuberculosis serine/threonine protein kinases PknA, PknB, and
PknL (2), encoded by the genes cg0059, cg0057, and cg2388, respectively.
As M. tuberculosis PknB was recently shown to phosphorylate myco-
bacterial GarA in vitro (20), PknB is a favorite candidate for PknG-
independent OdhI phosphorylation.
To confirm that OdhI is a substrate of PknG, both proteins were
synthesized as Strep-tagged derivatives and purified to apparent homo-
geneity. As shown by in vitro kinase assays, PknG catalyzed autophos-
phorylation and transphosphorylation of OdhI, whereas OdhI alone did
not incorporate 32P (Fig. 2A). By comparing the tryptic peptide mass
fingerprints of phosphorylated and unphosphorylatedOdhI, the amino-
terminal peptide covering amino acid residues 2–19was found to be the
only one phosphorylated by PknG (Fig. 3, A and B). Post-source decay
analysis of this peptide identified threonine 14 as the phosphorylated
residue (Fig. 3C). This result was verified by in vitro kinase assays, which
showed that a T14A exchange in OdhI abolished PknG-dependent
phosphorylation (Fig. 2A). In contrast, a T15A exchange only reduced
the phosphorylation efficiency, indicating that Thr-15 might be
involved in the binding of OdhI to PknG. OdhI/GarA homologous pro-
teins with a strictly conserved ETTSmotif in the amino-terminal region
occur in all species that contain PknG homologs (Fig. 2B). The first
threonine residue of this motif is the one phosphorylated by PknG in C.
glutamicum, and the second threonine residue corresponds to Thr-22
of GarA fromM. tuberculosis that was shown to be phosphorylated by
PknB (20).
Functional Characterization of the PknG Substrate OdhI—To address
the in vivo function of OdhI, in particular its involvement in glutamine
utilization, its structural gene was deleted inC. glutamicumwild type as
well as in the pknGmutant. Additionally, the odhImutant was trans-
formed with plasmids pJC1-odhI, pJC1-odhI-T14A, or pJC1-odhI-T15A
directing the synthesis of Strep-tagged OdhI, OdhI-T14A, or OdhI-T15A,
respectively. The odhImutant was able to grow on glutamine, and the
defect of the pknG mutant in glutamine utilization was abolished by
additional deletion of odhI (Fig. 3C), showing that OdhI is an essential
component of the PknG signaling pathway and pointing to an inhibitory
function of unphosphorylatedOdhI. Consistently, theodhI strain syn-
thesizing the OdhI-T14A protein could not grow on glutamine agar
plates, whereas the one with the OdhI-T15A protein could (Fig. 3C). In
summary, the presence of OdhI, which cannot be phosphorylated on
Thr-14 by PknG, inhibited growth on glutamine and consequently glu-
tamate degradation.
In contrast to proteins containing the FHA domain as part of a larger
protein whose activity is modulated by phosphorylation (21, 22), the
FHA domain of the OdhI protein is flanked only by an amino-terminal
extension of about 50 amino acid residues. This suggested that OdhI
exerts its inhibitory function in glutamate catabolism by interaction
with other cellular proteins. To identify OdhI interaction partners, plas-
mid-encoded Strep-tagged OdhI-T14A was purified from C. glutami-
cum strain odhI. As shown in Fig. 4A, large amounts of a protein with
an apparent mass of 140 kDa were copurified, which was identified by
mass spectrometry as OdhA (cg1280), the E1o subunit of the 2-oxo-
glutarate dehydrogenase complex (23). In contrast, only small amounts
of OdhA were copurified with unmutated OdhI from strain odhI/
pJC1-odhI, which was present predominantly in the phosphorylated
form, suggesting thatOdhA interacts preferablywith unphosphorylated
OdhI (Fig. 4A, lane 2). This was further strengthened by copurification
of unphosphorylated OdhI with Strep-tagged OdhA (Fig. 4A, lane 3).
The phenotype of the odhI mutants along with the observation that
FIGURE 2. Phosphorylation of OdhI by PknG and role of OdhI for glutamine utilization. A, autoradiogram showing in vitro phosphorylation of OdhI by PknG at threonine 14. A
T14A exchange in OdhI abolishes phosphorylation, whereas a T15A exchange does not. 61 pmol of OdhI or the indicated variants were incubated with 5.6 pmol of PknG and 37 kBq
[-32P]ATP for 30min at 37 °C, denatured, and completely loadedon a 15%SDSgel.B, alignment of the amino-terminal regions ofOdhI homologs fromdifferentActinomycetales. The
filled circle denotes the residue in C. glutamicumOdhI that is phosphorylated by PknG and the open circle the residue of theM. tuberculosisOdhI homolog (designated GarA), which
is phosphorylated in vitroby PknB (20).Ce,Corynebacterium efficiens;Cj,Corynebacterium jeikeium;Mp,Mycobacteriumavium subsp. paratuberculosis;Mb,M. bovis;Mt,M. tuberculosis;
Ms, M. smegmatis; Rf, Rhodococcus fascians; Sa, S. avermitilis; Sc, S. coelicolor. C, growth with glutamine as sole carbon source of the following C. glutamicum strains: 1, wild type; 2,
pknG; 3, odhI; 4, pknGodhI; 5, odhI/pJC1; 6, odhI/pJC1-odhI-T14A; 7, odhI/pJC1-odhI-T15A.
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FIGURE 3.Mapping of the PknG-dependent phosphorylation site of OdhI. Peptide mass fingerprints of tryptic digests of unphosphorylated (A) and in vitro phosphorylated (B)
Strep-taggedOdhI. Peaks are labeledwith theirmonoisotopicmasses and theassignedaminoacid residues are shown inparentheses.Thecovered sequence (87%of153aminoacids)
includedall serine and threonine residues. Theputativephosphopeptide ismarkedwith anasterisk. C,post-sourcedecay analysis of theOdhI phosphopeptide (averagemass 2059.0).
For noise filtering and smoothing, theData Explorer software (Applied Biosystems)was used. Fragment ions attributable to the y-serieswithin amass accuracy of 0.7Dawere labeled.
-Elimination of phosphoric acid (mass shift98) is indicated.
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ODH activity is crucial for glutamate catabolism (24) led us to suppose
that unphosphorylated OdhI can function as an inhibitor of ODH.
Purification of a Mixed ODHPDH Complex—Generally, ODH is a
large multienzyme complex consisting of oxoglutarate dehydrogenase
(E1o), dihydrolipoamide succinyltransferase (E2o), and dihydro-
lipoamide dehydrogenase (E3) subunits. The proteins encoded by sucB
(cg2421) and lpd (cg0790) were annotated as putative E2 and E3 sub-
units of ODH in C. glutamicum (16), and Lpd has been biochemically
characterized as dihydrolipoamide dehydrogenase (25). Remarkably,
corynebacteria and mycobacteria display two unusual features with
respect to ODH. The E1o subunit carries an amino-terminal extension
bearing sequence similarity to the catalytic domain of E2 subunits (23)
(Fig. 4B). Moreover, only a single dihydrolipoamide acyltransferase is
present in these bacteria (26), in contrast to most other organisms with
distinct E2 subunits for ODH and the related PDH complex. Therefore
the subunit composition of ODH remained somewhat puzzling. In M.
tuberculosis, PDH activity could be reconstituted with recombinant
AceE, SucB, and Lpd, but no ODH activity was observed by combining
SucA (60% sequence identity to C. glutamicum OdhA), SucB, and Lpd
(26). Instead, SucA was shown to possess a low 2-oxoglutarate decar-
boxylase activity (27). However, the inability to detect ODH activity in
mycobacterial cell extracts aswell aswith purified proteinsmight be due
to an unusual low stability of this enzyme complex as reported for C.
glutamicum (13). This instability was also reflected by the fact that our
standard purification protocol for Strep-tagged OdhA was not suitable
to enrich the putative E2 andE3 subunits ofODH in significant amounts
from strainWT-odhASt (Fig. 4A, lane 3). Therefore, an altered protocol
was developed, which allowed enrichment of ODH activity up to an
activity of 2.5 units/mg protein. The proteins copurified with Strep-
tagged OdhA included SucB (E2) and Lpd (E3), confirming that these
three proteins constitute ODH in C. glutamicum (Fig. 4C, lane 1). Sur-
prisingly, minor amounts of AceE, the E1p subunit of PDH (28), were
also copurified, and the eluate showed a PDH activity of 0.3 units/mg
protein. Vice versa, purification of Strep-tagged AceE from strain WT-
aceESt led to copurification of OdhA, SucB, and Lpd (Fig. 4C, lane 2),
and again, the eluate showed both ODH and PDH activity of 0.7 and 1.9
units/mg, respectively. These findings strongly suggest the existence of
mixed complexes composed of OdhA, AceE, SucB, and Lpd possessing
both ODH and PDH activity.
ODH Activity Is Inhibited by Unphosphorylated OdhI—To verify the
assumed function of OdhI as an inhibitor of ODH activity, we first
measured the ODH activity in cell extracts of C. glutamicum strain
pknGodhI lacking endogenous PknG and OdhI upon addition of
purified, unphosphorylatedOdhI. As shown in Fig. 5A, this resulted in a
concentration-dependent hyperbolic inhibition of ODH activity. Half-
maximal inhibition was observed at 4.3 nM OdhI. For a more detailed
analysis of the inhibition pattern, ODH activity was measured at oxo-
glutarate concentrations between 0.08 and 1.5 mM and different fixed
OdhI concentrations. Primary plots, e.g. according to Lineweaver and
Burk, were nonlinear, thereby indicating a slightly positive cooperative
binding of oxoglutarate (data not shown), as reported for ODH from
other organisms (29). The best linear fits in primary Eadie-Scatchard
plots (Fig. 5B, v/[S]n versus v) were obtained by using aHill coefficientnH
of 1.24. In these plots, the activities at different OdhI concentrations
gave a series of nearly parallel lines with slopes of 1/ Kapp and inter-
section points with the abscissa at Vmax(app). For noninhibited ODH, a
Vmax value of 94 milliunits/mg and an [S]0.5 value of 0.22 mM (K 
[S]0.5n ) were determined. Double-reciprocal replots of Vmax minus
Vmax(app) (Vm) and Kapp minus K (K) versus the inhibitor concen-
tration yielded parabolic curves (Fig. 5B, inset). From the intersection
points of these replots with the ordinate, values for of 1.63 and for of
0.024 were calculated (nomenclature according to Ref. 30). The latter
value has to be treated with caution because the very low ODH activity
at highOdhI concentrations is difficult tomeasure. From these results it
can be concluded that OdhI acts as a partial mixed type, essentially
noncompetitive inhibitor with respect to oxoglutarate. Application of a
linear equation for hyperbolic tight-binding inhibition (31) yielded a Ki
value of 2.4 nM.
By using affinity-purified ODH, it was possible to study the influence
of PknG-dependent phosphorylation of OdhI on ODH activity without
possible interferences from other protein kinases, phosphatases, and
ATPases present in cell extracts. As shown above with cell extract, addi-
tion of unphosphorylatedOdhI inhibitedODHactivity. Upon phospho-
rylation of OdhI by PknG, no inhibition but even a slight stimulation of
FIGURE 4. Interaction of unphosphorylated
OdhI with the E1 subunit (OdhA) of ODH and
evidence for amixed 2-oxoglutarate-pyruvate
dehydrogenase complex. A, copurification of
native OdhA with Strep-tagged OdhI-T14A from
C. glutamicum odhI/pJC1-odhI-T14A (lane 1) or
with Strep-tagged OdhI from C. glutamicum
odhI/pJC1-odhI (lane 2) and copurification of
native OdhI with Strep-tagged OdhA from C. glu-
tamicum WT-odhASt (lane 3). Note that pyruvate
carboxylase (Pyc) and acyl-CoA carboxylase
(AccBC, DtsR1, DtsR2) were copurified because of
direct binding of their biotin prosthetic groups to
the Strep-Tactin-Sepharose matrix. B, domain
organization of the E1 (OdhA) and E2 (SucB) sub-
units of ODHof C. glutamicum. L, linker; LBD, lipoyl
binding domain; P, peripheral subunit binding
domain. C, purification of amixed 2-oxoglutarate-
pyruvate dehydrogenase complex consisting of
the E1 subunits of ODH (OdhA), PDH (AceE), E2
(SucB), and E3 (Lpd) either via Strep-taggedOdhA
from C. glutamicum WT-odhASt (lane 1) or via
Strep-tagged AceE from C. glutamicumWT-aceESt
(lane 2).
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ODH activity was observed (Fig. 5C), providing further evidence that
only the unphosphorylated form of OdhI acts inhibitory. The stimula-
tion can be explained by the assumption that partial inhibition of ODH
caused by small amounts of copurified OdhI was abolished after
phosphorylation by PknG. The phosphorylation status of OdhI in
these experiments was confirmed by SDS-PAGE (Fig. 5C, upper
part) and mass spectrometric analysis. In contrast to ODH, no indi-
cations for an influence of OdhI or PknG on PDH activity were found
(data not shown).
DISCUSSION
The finding that PknG regulates ODH activity via the phosphoryla-
tion status of OdhI represents the first example for participation of
serine/threonine protein kinases in the control of this key enzyme of the
tricarboxylic acid cycle. In contrast to the well known regulation of
mitochondrial PDH activity via phosphorylation of E1p by pyruvate
dehydrogenase kinase (32), the mechanism shown here for ODH does
not involve direct phosphorylation ofODH subunits by PknG. Rather, it
requires the small soluble protein OdhI to mediate signal transduction
fromPknG, which is at least partiallymembrane-associated (4, 12),3 and
from membrane integral serine/threonine protein kinases like PknB to
cytosolic ODH. Control of the OdhI phosphorylation status by several
protein kinases allows integration of different environmental signals to
optimally adjust carbon flux distribution at the 2-oxoglutarate node to
the prevailing conditions. This mechanism is of particular importance
for the biotechnological production of about 1.5 million tons/year of
L-glutamate with coryneform bacteria, where attenuation of ODH ac-
tivitywas found to be the key factor in themetabolic network (33). It was
shown previously that treatments leading to glutamate excretion, e.g.
biotin limitation, addition of certain detergents or antibiotics, or culti-
vation of temperature-sensitive strains at higher temperature, are
accompanied by a decrease in ODH activity, but the mechanism
remained enigmatic (34, 35). Because of the regulatory function of OdhI
and its presumed ability to respond to different stimuli, this protein is the
prime candidate for linking the various treatments with the observedmet-
abolic response and therefore a promising target for improving amino acid
production.
Considering that the proteins PknG, OdhI (GarA, respectively), and
OdhA are highly conserved in corynebacteria and mycobacteria, the
signaling cascade involving these proteins might operate also in myco-
bacteria, an assumption supported by the increased intracellular gluta-
mate/glutamine level measured in anM. tuberculosis pknG strain (4).
PknG is dispensable for growth ofM. bovis (17) as well as of C. glutami-
cum in nutrient-rich media. InM. tuberculosis, the growth defect of the
pknG mutant was most pronounced in nutrient-depleted media, and
an involvement of PknG in sensing nutritional stress was proposed (4).
This agrees with our preliminary observation of increased levels of phos-
phorylated OdhI in carbon-starved C. glutamicum (data not shown).
Although the metabolism of mycobacteria growing inside macrophages
is poorly understood, it has been shown that fatty acids serve as carbon
source via the glyoxylate pathway (36), and the tricarboxylic acid cycle is
thought to be required to drive ATP synthesis (37). The importance of
an intact tricarboxylic acid cycle is further supported by the finding that
OdhA is required for growth ofM. tuberculosis (38). Thus, besides the
postulated interference of secreted PknG with host cell signaling path-
ways (3), delayed virulence and decreased ability to block phagosome-
lysosome fusion of mycobacteria lacking PknG might also be explained
by a disturbed energy metabolism because of inhibition of ODH.
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FIGURE 5. Regulation of ODH activity by the
phosphorylation status of OdhI. A, concentra-
tion-dependent inhibition of ODH activity in cell
extractsofC. glutamicumpknGodhIbyaddition
of purified, unphosphorylated OdhI. The line rep-
resents the fit of themeasured data to the general
velocity equation for hyperbolic mixed type inhi-
bition (30). B, Eadie-Scatchard plot (using a Hill
coefficientn1.24) ofODHactivity in cell extracts
at varyingoxoglutarate concentrations (0.08, 0.25,
0.5, and 1.5 mM) and different fixed OdhI concen-
trations: 0 nM (filled circles), 0.9 nM (open circles), 1.8
nM (filled triangles), 3.6 nM (open triangles), 6.1 nM
(filled squares, 12.1 nM (open squares), and 30.4 nM
(filled diamonds). The solid lines represent linear
fits of the data; the dashed lineswere calculated as
connection to the common intersection point.
The inset shows a double-reciprocal replot of Vmax
minus Vmax(app) (Vm; filled circles) and Kappminus
K (K;open circles) versus theOdhI concentration
as calculated fromtheprimaryplot.C, inhibitionof
ODH activity by OdhI is abolished by PknG-
dependent phosphorylation of OdhI. 2g of ODH
complex purified from C. glutamicum pknG-
odhAStwas incubated for 1hbefore activity assays
(in triplicate) either without additives (bar 1), or
with 0.2 g of OdhI and 2 mM ATP (bar 2), or with
0.2 g of OdhI, 2 mM ATP and 2.2 g of PknG (bar
3). The phosphorylation status of OdhI was veri-
fied by SDS-PAGE and mass spectrometric analy-
sis: bar 1, native unphosphorylated OdhI; bar 2,
native and Strep-tagged unphosphorylated OdhI;
bar 3, native and Strep-tagged phosphorylated
OdhI.
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